ReBio Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma (NCT07747935) | ReBio Pharma | 2026-10-01 |
Track ReBio Pharma automatically
Every clearance here is in the API, with alerts when new ones post.